| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/16/1997 | CN1147813A Novel selective inhibitors of viral or bacterial neuraminidases |
| 04/16/1997 | CN1147769A Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
| 04/16/1997 | CN1147519A Preparation of d4T from 5-methyluridine |
| 04/16/1997 | CN1147399A Prepn process of multi-purpose sanitary embolus |
| 04/16/1997 | CN1034571C A method for producing a pyrrolidire derivative |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/16/1997 | CN1034554C Producing process for cell free marek's disease virus vaccine |
| 04/15/1997 | US5621105 Reacting halo-substituted quinolonecarboxylic acid or naphthyridonecarboxylic acid with 1-aminomethyl-2-oxa-7-azabicyclo/3.3.0/octane |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621095 Cephalosporins |
| 04/15/1997 | US5620997 Viricides, antiinflammatory agents, antiatherosclerotic agent |
| 04/15/1997 | US5620987 Amino acid derivatives |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620954 Peptide compositions and uses therefor |
| 04/15/1997 | US5620858 Method of removing shiga-like toxins from biological samples |
| 04/15/1997 | US5620702 Adhesive bandages, wound dressings, sutures, drapes orthodontic rubber bands, toothbrushes, and the like |
| 04/15/1997 | US5620691 Polypeptide vaccine |
| 04/10/1997 | WO1997012967A1 Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication |
| 04/10/1997 | WO1997012909A1 Novel membrane proteins of helicobacter pylori |
| 04/10/1997 | WO1997012908A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012901A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | WO1997012890A1 New cephem compounds |
| 04/10/1997 | WO1997012889A1 Penicillin glycolate |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012874A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 04/10/1997 | WO1997012868A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997012617A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | WO1997012521A1 Antiparasitic composition for treating and protecting pets |
| 04/10/1997 | WO1997006798A3 Pharmaceutical formulations |
| 04/10/1997 | CA2234229A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | CA2233935A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2229785A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2206797A1 Novel membrane proteins of helicobacter pylori |
| 04/10/1997 | CA2206708A1 Novel membrane proteine p76 of helicobacter pylori |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |
| 04/09/1997 | EP0767172A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection |
| 04/09/1997 | EP0766740A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 04/09/1997 | EP0766739A1 66 kDa ANTIGEN FROM BORRELIA |
| 04/09/1997 | EP0766689A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 04/09/1997 | EP0766688A1 Synthesis of oligonucleotides |
| 04/09/1997 | EP0766685A1 Aryl, alkyl, alkenyl, and alkynylmacrolides |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0766674A1 New hiv protease inhibitors |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0630381B1 Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives |
| 04/09/1997 | EP0538305B1 Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections |
| 04/09/1997 | CN1147259A Method of separating protective components of bordetella pertussis |
| 04/09/1997 | CN1147253A Novel crystal forms of 1-[5-methanesulfonamido indolyl-2-carbonyl]-4-[3(1-methylethylamino)-2-pyridinyl] piperazine |
| 04/09/1997 | CN1147204A Use of spiramycin for treating |
| 04/09/1997 | CN1147015A Marek's Disease Vaccine |
| 04/09/1997 | CN1034506C Method for preparing medicinal composition contg. glycopeptide derivs. |
| 04/09/1997 | CN1034504C Process for preparing thioalkylthio cephalosporin derivs. |
| 04/08/1997 | US5618939 Reacting of an amine nucleophile with an activated glycidylcompound in presence of a strong base at low temperature |
| 04/08/1997 | US5618928 Triazenyl-substituted phenyl pyrimidines and their use in therapy |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618849 Picornavirus, enterovirus, polio virus, coxsackie virus, echo virus |
| 04/08/1997 | US5618847 Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish |
| 04/08/1997 | US5618840 Prevention growth of helicobacter |
| 04/08/1997 | US5618820 1,3-oxathiolane nucleoside analogues and methods for using same |
| 04/08/1997 | US5618815 1,9-bridged thiazolo[3,2-a]quinoline derivatives |
| 04/08/1997 | US5618803 Targeted drug delivery via phosphonate derivatives |
| 04/08/1997 | US5618799 Storage stability, noncaking, nonscattering, adhesion |
| 04/08/1997 | US5618787 Cyclic peptide antifungal agents |
| 04/08/1997 | US5618666 Nucleic acids derived from Salmonella typhi and detection of Salmonella using thereof |
| 04/08/1997 | US5618564 Composition for the treatment of helicobacter pylori infection |
| 04/08/1997 | US5618541 Vaccine against Neisseria meningitidis infections |
| 04/08/1997 | US5618540 Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
| 04/03/1997 | WO1997012043A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | WO1997012032A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 04/03/1997 | WO1997011713A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | WO1997011707A1 Modified ether glyceroglycolipids |
| 04/03/1997 | WO1997011667A2 Therapeutic applications using horse serum |
| 04/03/1997 | WO1997011666A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 04/03/1997 | WO1997011605A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | WO1997011598A1 Method for treating hepatitis virus infection |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | WO1996038473A3 Antimicrobial cationic peptides |
| 04/03/1997 | DE19531226C1 Pharmaceutical compsn. for prevention or treatment of viral disease |
| 04/03/1997 | CA2233445A1 2-mercaptoethanolamine, copper di-isopropyl salicylate, and related compounds |
| 04/03/1997 | CA2233278A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233168A1 Modified ether glyceroglycolipids |
| 04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | CA2233015A1 Therapeutic applications using horse serum |
| 04/03/1997 | CA2230933A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/02/1997 | EP0765879A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests |
| 04/02/1997 | EP0765873A1 Cyclic ureas and analogues useful as retroviral protease inhibitors |
| 04/02/1997 | EP0765665A1 Use of dideoxy nucleoside analogues in the treatment of viral infections |
| 04/02/1997 | EP0765662A1 Hiv growth inhibitory composition |